PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer

Gastric cancer (GC) is a major health burden worldwide, but our understanding of GC is limited, and the prognosis is poor. Novel therapeutic strategies and biomarkers are urgently needed to improve GC patient outcomes. Previously, we identified PFDN2 as a novel key gene in gastric cancer based on it...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qiuming, Ding, Zheyu, Chen, Tingna, Wu, Haitao, Song, Jialing, Xiang, Zhenxian, Yang, Chaogang, Wang, Shuyi, Xiong, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395514/
https://www.ncbi.nlm.nih.gov/pubmed/37538116
http://dx.doi.org/10.3389/fonc.2023.1164070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395514/
https://www.ncbi.nlm.nih.gov/pubmed/37538116
http://dx.doi.org/10.3389/fonc.2023.1164070

Ejemplares similares